Megna Michael R
SEC insider (Form 3/4/5 filer). CIK 0001464583. CHIEF ACCOUNTING OFFICER at Kiniksa Pharmaceuticals International, plc (KNSA). 76 reported Form 4/5 transactions since Sep 2024; latest on Sep 3, 2026. Located in LONDON.
Companies Megna Michael R has filed insider reports for
- Kiniksa Pharmaceuticals International, plc (KNSA): Officer, CHIEF ACCOUNTING OFFICER
Megna Michael R
CIK: 0001464583
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Kiniksa Pharmaceuticals International, plc
Discretionary Trading P&L
Holdings
Transaction History (76 total)
- Sep 3, 2026KNSA
Kiniksa Pharmaceuticals International, plc
SaleDirect4.6K shares at avg. $80.30$369K - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect2.6K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectRestricted Share Unit
3.7K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
Tax PaymentDirect5.5K shares at avg. $79.28$438K - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectShare Option
14.6K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect3.9K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect2.6K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect2.4K shares- - Jul 15, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirect279 shares at avg. $33.50$9K - Apr 9, 2026KNSA
Kiniksa Pharmaceuticals International, plc
SaleDirect6.6K shares at avg. $46.69$309K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 3, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 4,600 | $80.30 | $369,380 | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 2,558 | - | $0 | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Restricted Share Unit | 3,650 | - | - | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Tax Payment | 5,531 | $79.28 | $438,498 | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Share Option | 14,600 | - | - | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 3,932 | - | $0 | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 2,644 | - | $0 | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 2,362 | - | $0 | Direct |
| Jul 15, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award | 279 | $33.50 | $9,347 | Direct |
| Apr 9, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 6,625 | $46.69 | $309,321 | Direct |
1-10 of 76 transactions